<DOC>
	<DOCNO>NCT00000326</DOCNO>
	<brief_summary>The purpose study assess clinical efficacy buprenorphine/naloxone combination tablet alternate-day dose determine whether multiple daily dose necessary maintain effective alternate day dose regimen .</brief_summary>
	<brief_title>Buprenorphine/Naloxone Treatment Opioid Dependence-Experiment 1 - 1</brief_title>
	<detailed_description>Alternate-day dose 8mg buprenorphine-naloxone tablet safe effective daily dose . Outcomes improved total weekly dose provide alternate-day dose equal give daily dose .</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Heroin Dependence</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Buprenorphine , Naloxone Drug Combination</mesh_term>
	<mesh_term>Heroin</mesh_term>
	<criteria>Individuals must currently opioid dependent meet FDA criterion narcotic maintenance treatment . Comorbid substance abuse dependence disorder may also present . Individuals must healthy despite drug dependency . Individuals evidence active Diagnostic Statistical Manual Mental Disorders ( DSMIV ) Axis I psychiatric disorder ( e.g . psychosis , manicdepressive illness , organic psychiatric disorder ) , significant medical illness ( e.g . liver cardiovascular disease ) pregnant female subject exclude study participation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Heroin Dependence</keyword>
</DOC>